Theramex SpA
5 articles about Theramex SpA
-
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
10/10/2023
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and Femoston® from Viatris Inc.
-
Theramex Appoints Sigurd Kirk to the Board of Directors
7/12/2021
Theramex has announced that Sigurd (Sig) Kirk has been appointed as a member of the Board of Directors for Theramex.
-
TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
6/7/2019
TherapeuticsMD, Inc. announced that it has entered into an exclusive license and supply agreement with Theramex, a leading, global specialty pharmaceutical company dedicated to women’s health, to commercialize BIJUVA and IMVEXXY outside of the United States.
-
Teva Pharmaceutical Industries Limited Completes Acquisition of Theramex SpA
1/5/2011
-
Teva Pharmaceutical Industries Limited to Acquire Theramex SpA, Merck KGaA’s European Based Women’s Health Business; Teva To Pay $367 Million at Closing
10/28/2010